1. Home
  2. RYTM vs BRC Comparison

RYTM vs BRC Comparison

Compare RYTM & BRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • BRC
  • Stock Information
  • Founded
  • RYTM 2008
  • BRC 1914
  • Country
  • RYTM United States
  • BRC United States
  • Employees
  • RYTM N/A
  • BRC N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • BRC Miscellaneous manufacturing industries
  • Sector
  • RYTM Health Care
  • BRC Consumer Discretionary
  • Exchange
  • RYTM Nasdaq
  • BRC Nasdaq
  • Market Cap
  • RYTM 4.3B
  • BRC 3.3B
  • IPO Year
  • RYTM 2017
  • BRC 1984
  • Fundamental
  • Price
  • RYTM $65.25
  • BRC $69.32
  • Analyst Decision
  • RYTM Strong Buy
  • BRC
  • Analyst Count
  • RYTM 12
  • BRC 0
  • Target Price
  • RYTM $77.50
  • BRC N/A
  • AVG Volume (30 Days)
  • RYTM 560.2K
  • BRC 248.6K
  • Earning Date
  • RYTM 08-05-2025
  • BRC 05-16-2025
  • Dividend Yield
  • RYTM N/A
  • BRC 1.41%
  • EPS Growth
  • RYTM N/A
  • BRC 3.35
  • EPS
  • RYTM N/A
  • BRC 4.03
  • Revenue
  • RYTM $136,863,000.00
  • BRC $1,459,732,000.00
  • Revenue This Year
  • RYTM $37.56
  • BRC $13.02
  • Revenue Next Year
  • RYTM $74.99
  • BRC $3.76
  • P/E Ratio
  • RYTM N/A
  • BRC $16.93
  • Revenue Growth
  • RYTM 48.88
  • BRC 8.62
  • 52 Week Low
  • RYTM $40.46
  • BRC $62.70
  • 52 Week High
  • RYTM $69.89
  • BRC $77.68
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 53.08
  • BRC 46.32
  • Support Level
  • RYTM $60.80
  • BRC $67.66
  • Resistance Level
  • RYTM $64.00
  • BRC $69.29
  • Average True Range (ATR)
  • RYTM 1.96
  • BRC 1.34
  • MACD
  • RYTM -0.13
  • BRC 0.08
  • Stochastic Oscillator
  • RYTM 44.48
  • BRC 55.84

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About BRC Brady Corporation

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.

Share on Social Networks: